83 related articles for article (PubMed ID: 21033215)
1. Fecal RNA detection of cytokeratin 19 and ribosomal protein L19 for colorectal cancer.
Yang SH; Huang CJ; Lee CL; Liu CC; Chien CC; Chen SH
Hepatogastroenterology; 2010; 57(101):710-5. PubMed ID: 21033215
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic significance of cytokeratin 19 and 20 expression on micrometastasis of colorectal cancer].
Yu YJ; Liu YD; Xu X; Ma XW
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):48-51. PubMed ID: 19145504
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
4. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
5. HERG1 gene expression as a specific tumor marker in colorectal tissues.
Dolderer JH; Schuldes H; Bockhorn H; Altmannsberger M; Lambers C; von Zabern D; Jonas D; Schwegler H; Linke R; Schröder UH
Eur J Surg Oncol; 2010 Jan; 36(1):72-7. PubMed ID: 19577877
[TBL] [Abstract][Full Text] [Related]
6. Potential of faecal RNA in diagnosing colorectal cancer.
Yang SH; Chien CC; Chen CW; Li SY; Huang CJ
Cancer Lett; 2005 Aug; 226(1):55-63. PubMed ID: 16004932
[TBL] [Abstract][Full Text] [Related]
7. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
[TBL] [Abstract][Full Text] [Related]
8. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
[TBL] [Abstract][Full Text] [Related]
9. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
10. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis.
Illert B; Fein M; Otto C; Cording F; Stehle D; Thiede A; Timmermann W
Scand J Gastroenterol; 2005 Jul; 40(7):843-9. PubMed ID: 16109661
[TBL] [Abstract][Full Text] [Related]
11. CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor.
Chen TF; Jiang GL; Fu XL; Wang LJ; Qian H; Wu KL; Zhao S
Lung Cancer; 2007 Apr; 56(1):105-14. PubMed ID: 17166620
[TBL] [Abstract][Full Text] [Related]
12. A homologue of the Drosophila headcase protein is a novel tumor marker for early-stage colorectal cancer.
Chien CC; Chang CC; Yang SH; Chen SH; Huang CJ
Oncol Rep; 2006 Apr; 15(4):919-26. PubMed ID: 16525680
[TBL] [Abstract][Full Text] [Related]
13. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
[TBL] [Abstract][Full Text] [Related]
14. Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease.
Gradilone A; Gazzaniga P; Silvestri I; Gandini O; Trasatti L; Lauro S; Frati L; Aglianò AM
Oncol Rep; 2003; 10(1):217-22. PubMed ID: 12469172
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
16. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
[TBL] [Abstract][Full Text] [Related]
17. Fecal protein markers of colorectal cancer.
Dubrow R; Yannielli L
Am J Gastroenterol; 1992 Jul; 87(7):854-8. PubMed ID: 1615938
[TBL] [Abstract][Full Text] [Related]
18. [Fecal methylated DNA for the detection of colorectal cancer].
von Delius S; Jung A; Schmid RM
Z Gastroenterol; 2006 Sep; 44(9):1001-2. PubMed ID: 16981074
[No Abstract] [Full Text] [Related]
19. [Cytokeratin 20 as a marker of tumor progression or dissemination in patients with colorectal cancer].
Garrido S M; Ramírez V P; Risueño A C; Orellana U E; Galindo A H; Alvarez Z M
Rev Med Chil; 2008 Apr; 136(4):482-90. PubMed ID: 18769791
[TBL] [Abstract][Full Text] [Related]
20. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer.
Iinuma H; Okinaga K; Egami H; Mimori K; Hayashi N; Nishida K; Adachi M; Mori M; Sasako M
Int J Oncol; 2006 Feb; 28(2):297-306. PubMed ID: 16391782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
